Federation des caisses Desjardins du Quebec’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio BBC Stock Details BBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.58K	Hold	110	–	–	﹤0.01%	2520
2025 Q4	$4.24K	Hold	110	–	–	﹤0.01%	2486
2025 Q3	$3K	Hold	110	–	–	﹤0.01%	2549
2025 Q2	$2.13K	Sell	110 -184	-63%	-$3.34K	﹤0.01%	2401
2025 Q1	$5.16K	Hold	294	–	–	﹤0.01%	2163
2024 Q4	$7.04K	Sell	294 -544	-65%	-$15K	﹤0.01%	1989
2024 Q3	$23.4K	Hold	838	–	–	﹤0.01%	1617
2024 Q2	$21.2K	Hold	838	–	–	﹤0.01%	1605
2024 Q1	$24.4K	Hold	838	–	–	﹤0.01%	1582
2023 Q4	$20.5K	Hold	838	–	–	﹤0.01%	1569
2023 Q3	$16.4K	Hold	838	–	–	﹤0.01%	1635
2023 Q2	$20.1K	Hold	838	–	–	﹤0.01%	1577
2023 Q1	$18.4K	Hold	838	–	–	﹤0.01%	1593
2022 Q4	$20.9K	Hold	838	–	–	﹤0.01%	1670
2022 Q3	$20.6K	Hold	838	–	–	﹤0.01%	1722
2022 Q2	$18.1K	Hold	838	–	–	﹤0.01%	1795
2022 Q1	$23.4K	Hold	838	–	–	﹤0.01%	1781
2021 Q4	$32.3K	Hold	838	–	–	﹤0.01%	1705
2021 Q3	$38.3K	Hold	838	–	–	﹤0.01%	1678
2021 Q2	$41.9K	Hold	838	–	–	﹤0.01%	1664
2021 Q1	$43.1K	Buy	838 +300	+56%	+$16.4K	﹤0.01%	1593
2020 Q4	$26.7K	Hold	538	–	–	﹤0.01%	1666
2020 Q3	$21K	Buy	538 +428	+389%	+$17.4K	﹤0.01%	1475
2020 Q2	$4.75K	Hold	110	–	–	﹤0.01%	1817
2020 Q1	$3.22K	Hold	110	–	–	﹤0.01%	1913
2019 Q4	$4.19K	Hold	110	–	–	﹤0.01%	2057
2019 Q3	$2.62K	Hold	110	–	–	﹤0.01%	2063
2019 Q2	$3.17K	Sell	110 -100	-48%	-$2.79K	﹤0.01%	2066
2019 Q1	$5.98K	Hold	210	–	–	﹤0.01%	1781
2018 Q4	$4.88K	Hold	210	–	–	﹤0.01%	1775
2018 Q3	$7.26K	Hold	210	–	–	﹤0.01%	1801
2018 Q2	$6.87K	Hold	210	–	–	﹤0.01%	1846
2018 Q1	$6.89K	Buy	+210	New	+$6.85K	﹤0.01%	1802

Other funds holding BBC

KCP

Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MCM

Militia Capital Management Austin, Texas $454M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

APW

Aurora Private Wealth Rockaway, New Jersey $158M AUM

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's BBC Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Virtus Biotech Clinical Trials ETF (BBC) position steady in Q1 2026 at 110 shares worth $4.58K. The position accounts for ﹤0.01% of the portfolio, ranked #2520.

Federation des caisses Desjardins du Quebec first reported a position in BBC in Q1 2018 and has held it in 33 quarters since. The position peaked at $43.1K in Q1 2021. 20 funds tracked by Wall St. Rank hold BBC as of Q1 2026.

Federation des caisses Desjardins du Quebec held 110 shares of Virtus Biotech Clinical Trials ETF worth $4.58K as of Q1 2026.
Federation des caisses Desjardins du Quebec left its Virtus Biotech Clinical Trials ETF share count unchanged in Q1 2026.
Virtus Biotech Clinical Trials ETF made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2520 holding.
Federation des caisses Desjardins du Quebec first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2018 and has held it in 33 quarters since.
Federation des caisses Desjardins du Quebec's Virtus Biotech Clinical Trials ETF position peaked at $43.1K in Q1 2021.
20 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.